Mira Pharmaceuticals (MIRA) Stock Analysis: AI Score & Alternative Data
MIRA alt-data: web traffic climbing, headcount lagging
Is Mira Pharmaceuticals a buy right now? The alternative data says hold. This MIRA stock analysis is built on the 25+ alternative data signals AltIndex tracks on Mira Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 54/100: a Hold. The stock trades at $0.79 with a $33M market cap.
The bullish side of the 90-day ledger: web traffic up 112.3% to 3K monthly visits. The drag: headcount (according to LinkedIn) down 14.3% to 6 employees. That tension is what keeps the score mid-range.
MIRA’s broader alt-data profile also covers X followers (14), and sentiment (100/100). Every signal links to its own page with full history, the MIRA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on MIRA is just below.
Mira Pharmaceuticals AI Stock Analysis
Mira Pharmaceuticals is a specialty pharmaceutical company that focuses on developing innovative drugs to address unmet medical needs. With a portfolio that spans various therapeutic areas, the company continually seeks to enhance its R&D efforts and streamline its operations.
Analysis generated September 3, 2026.
Recent Mira Pharmaceuticals Stock Alerts
|
Mira Pharmaceuticals | September 8 Price is up by 6.1% in the last 24h. |
|
Mira Pharmaceuticals | September 4 Price is up by 10.2% in the last 24h. |
|
Mira Pharmaceuticals | September 3 Price is down by -7% in the last 24h. |
|
Mira Pharmaceuticals | September 2 Price is up by 8.6% in the last 24h. |
Mira Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 3K | 112.3% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 6 | 14.3% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 6 | N/A | |
| Stocktwits Mentions | 8 | 14.3% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 1.2% | |
| X Followers | 14 | 7.7% | |
| Youtube Subscribers | 12 | 0% |
About Mira Pharmaceuticals (MIRA)
MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The company is headquartered in Baltimore, Maryland.
| Price | $0.79 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $33M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Mira Pharmaceuticals News
View more →
Orion, Shilpa Medicare expand partnership for nivolumab biosimilarJuly 6 - Thefly.com |
See Mira Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for MIRA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEMira Pharmaceuticals Earnings & Financial Performance
View all earnings →Mira Pharmaceuticals Insider Trading Activity
View all →| Aminov Erez filed to sell 3,592,666 shares at $0.0. Oct 16 '25 |
| Aminov Erez filed to sell 1,061,200 shares at $0.0. Nov 20 '24 |
| Aminov Erez filed to sell 1,105,790 shares at $0.0. Nov 19 '24 |
| Bay Shore Trust filed to sell 2,540,270 shares at $0.0. Aug 28 '24 |
| Aminov Erez filed to sell 377,000 shares at $0.0. May 21 '24 |
Mira Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Mira Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Scilex HoldingSCLX |
$5.05 2.9% | $37M | 38 |
 |
TherapeuticsMDTXMD |
$2.10 0.9% | $25M | 38 |
 |
CleneCLNN |
$3.65 1.9% | $48M | 48 |
 |
GelteqGELS |
$0.79 7.4% | $9M | 53 |
 |
Sunshine BiopharmaSBFM |
$1.08 3.6% | $4M | 49 |
Explore Mira Pharmaceuticals Data
Frequently Asked Questions: Mira Pharmaceuticals (MIRA)
Mira Pharmaceuticals has an AltIndex AI Score of 54/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
54/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Mira Pharmaceuticals (MIRA) stock is $0.79 with a market cap of $33M.
As of today, Mira Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Mira Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Mira Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The MIRA stock price chart above shows Mira Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Mira Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Mira Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
